Lymph node metastasis and the clinical stage of OSCC were correlated with survivin expression at the genetic level, though no significant relationship between clinicopathological features and survivin overexpression at the protein level was identified (Table 2). The gene discussed is BIRC5; the disease is metastatic malignant neoplasm in the lymph nodes.